[ad_1]
The Hungarian government’s plan to import and possibly use a Russian coronavirus vaccine called Sputnik V raises safety concerns and could undermine general confidence in the vaccines, the European Commission said according to Reuters.
According to the article, it would be unprecedented for the Hungarian government to test and possibly manufacture the Russian vaccine. Under current regulations, the Russian vaccine cannot be marketed in member states until it has been approved by the European Medicines Agency (EMA), citing a spokesperson for the organization, hvg.hu. According to the committee, if the public begins to question the safety and efficacy of a vaccine, it will be much more difficult to vaccinate a large enough portion of the population to control the epidemic.
The Hungarian government did not respond to questions from Reuters about whether it wanted to authorize the Russian vaccine on its own or through necessary EU procedures. The government has previously announced that it intends to test and approve the vaccine, the first samples of which, according to Chancellor Péter Szijjártó, announced in Budapest on Thursday. If vaccination proves safe and effective, they would import larger quantities in early 2021 or begin mass production licensed domestically.
Are they a goalkeeper?
Viktor Orbán’s government can circumvent EU restrictions by using a loophole, as EU law allows the temporary import and distribution of unauthorized vaccines “in the event of a suspected or proven spread of pathogens, poisons, chemicals or harmful nuclear radiation “.
The issue of the Russian vaccine further heightens the tension between the Hungarian government and the European Commission; cites the article as hvg.hu.
Russians submitted certification request to WHO
Meanwhile, the MTI reported that Russia had submitted to the World Health Organization (WHO) a request for certification of its first vaccine against Covid-19, Sputnik V.
“The WHO has not even announced any vaccines, because before that all vaccines must go through the evaluation of the Emergency Use List system. This is a conditional certificate that is usually issued during a pandemic,” Vujovic told the radio. Eho Moscow. “All vaccines in the country have to go through such certification, the producers of Sputnik V from Russia have already submitted their certification law to the WHO headquarters,” he said.
Vujovic told Rosiah 24 news television that the Sputnik V developers had submitted the vaccine documentation to the WHO, “there is a” dialogue “between the developers and the health organization’s procedural evaluation department. As he said , “once the vaccine development process is complete”, WHO will post a notice on its website.
The human adenovirus-based vector vaccine Sputik V, developed by the Gamaleja Institute in Moscow, was registered on August 11 in Russia. The vaccine is based on a known method that has been used to develop other vaccines. According to the Russian Ministry of Health, in its experience, preparations based on a similar principle provide protection for up to two years.
According to the WHO, there are currently around 170 projects in the world to develop a new vaccine against coronavirus infection. Vujovic estimated that by the end of 2021, 2 billion people could be vaccinated if there is a sufficient amount of vaccine.
[ad_2]
